drugset / Trial / NCT01100437

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

NCT01100437

Phase 4 Terminated 14 enrolled Pfizer
RandomizedCrossoverTriple-blind

Summary

This study will evaluate whether crushed EMBEDA capsules induce clinical opiate withdrawal signs and symptoms in opioid-dependent patients with chronic non-cancer pain who are stabilized on EMBEDA.

Timeline

Start
2010-04
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject EMBEDA Unknown Oral

Indications